RE:Dec 18th last yearI think upper NPH management deserves attractive options (IMO Arun and co have performed perfectly) so no problem there for me......It always amazing me when people ask why are not insiders buying (not just NPH but many other successful companies listed as well)...... as you can see there is a bit of a conflict in the timing of insider buys (much better after the reset, if at all)..... I picked up some more shares last Friday after I heard somebody alse bought at $0.28 (was a buy signal) .... I feel NPH will surprise to the upside very soon, and this time it will not be one big price spike event like last time, maybe will be volatile but I am expecting it will overall track steady rising revenue (as others have said here).... also nice to know the runway for Vanc is farther than the eye can see (i.e. massive)... IMO the large Canada wide generics platform will make newer high margin drug makers looking for a CDN partner preferr NPH....NPH will be able to offer licencee's back NPH rights to some of their drugs/relationships; and also their independence and Canada wide coverage will make them a perfect choice for new products --- Generics acting like a magnet for the new opportunities... I also expect to see surprising growth in NPH OTC and Generics products offered (from what they have now) as well partly as a result of the critical mass achieved so quickly with the current large offering of generics..... should be exciting to see...